|
The document discusses the decision not to pursue a program for achieving a C-8 material balance for TEFLON employees due to recent findings on C-8 embryotoxicity and declining blood levels, while supporting additional blood sampling for certain employees and emphasizing the need for a detailed epidemiological study to determine safe blood levels of C-8.
|
1982 |
AR226-1620
|
1Q0q3EGrVKwKnB3n6pmY0LGYX |
1 |